Research Division of Clinical Pharmacology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.
Department of Allergy, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, P.R. China.
Mol Med Rep. 2017 Sep;16(3):2887-2892. doi: 10.3892/mmr.2017.6899. Epub 2017 Jun 30.
Platanus acerifolia pollen is considered an important source of airborne allergens in numerous cities. Pla a 1 is a major allergen from P. acerifolia pollen. The present study aimed to express and purify Pla a 1, and to prepare its monoclonal antibody. In the present study, the Pla a 1 gene was subcloned into a pET‑28a vector and transformed into the ArcticExpress™ (DE3) RP Escherichia coli host strain. The purified Pla a 1 was then used to immunize BALB/c mice. When serum detection was positive, spleen cells were isolated from the mice and fused with SP2/0 myeloma cells at a ratio of 10:1. Hybridoma cells were screened by indirect ELISA and limiting dilution. Positive cells were used to induce the formation of antibody‑containing ascites fluid, and the antibodies were purified using protein A‑agarose. The results of the present study demonstrated that recombinant Pla a 1 was successfully expressed and purified, and exhibited positive immunoglobulin E‑binding to serum from patients allergic to P. acerifolia. A total of 11 hybridomas that steadily secreted anti‑Pla a 1 antibody were obtained and an immunoblotting analysis indicated that all of these monoclonal antibodies specifically recognized the Pla a 1 protein. These results suggested that specific anti‑Pla a 1 antibodies may be obtained, which can be used for the rapid detection of Pla a 1 allergens and in the preparation of vaccines against P. acerifolia pollen.
悬铃木花粉被认为是许多城市空气中过敏原的重要来源。Pla a 1 是悬铃木花粉的主要过敏原之一。本研究旨在表达和纯化 Pla a 1 ,并制备其单克隆抗体。在本研究中,Pla a 1 基因被亚克隆到 pET-28a 载体中,并转化到 ArcticExpress™(DE3)RP 大肠杆菌宿主菌株中。然后,用纯化的 Pla a 1 免疫 BALB/c 小鼠。当血清检测呈阳性时,从小鼠中分离脾细胞,并以 10:1 的比例与 SP2/0 骨髓瘤细胞融合。通过间接 ELISA 和有限稀释法筛选杂交瘤细胞。用蛋白 A-琼脂糖纯化阳性细胞诱导形成含抗体的腹水,并用蛋白 A-琼脂糖纯化抗体。本研究结果表明,重组 Pla a 1 成功表达和纯化,并对悬铃木过敏患者的血清表现出阳性免疫球蛋白 E 结合。获得了 11 株稳定分泌抗 Pla a 1 抗体的杂交瘤细胞,免疫印迹分析表明,所有这些单克隆抗体均特异性识别 Pla a 1 蛋白。这些结果表明,可能获得特异性抗 Pla a 1 抗体,可用于快速检测 Pla a 1 过敏原,并制备悬铃木花粉疫苗。